InfuSystem sets new revenue record
By HME News Staff
Updated 9:28 AM CDT, Thu August 8, 2024
ROCHESTER HILLS, Mich. – InfuSystem Holdings reported revenues of $33.7 million for the second quarter of 2024, an increase of 6% year over year. Of that, Patient Services revenue was $20.2 million, and Device Solutions revenue was $13.5 million. Adjusted EBITDA margin was 18% vs. 18.2% year over year. “We are pleased with our second quarter financial results, which included setting a new record high quarterly revenue of $33.7 million, an increase of 6% over the prior year period, a 17% increase in net operating cash flow, and the anticipated significant sequential increase in adjusted EBITDA margin to 18%,” said Richard Dilorio, CEO. “This quarter marked our 10th consecutive record-breaking revenue achievement out of the last 12 quarters.” InfuSystem recently inked a three-year distribution agreement with Smith+Nephew to distribute its RENASYS EDGE NPWT system.
Comments